Investment Q&A

Q: As a new subscriber, I’m thoroughly impressed with your advice and 5i Research services overall - thank you for all that you do.

I currently hold ABBV, BMY, CVS, and GSK in a long-term hold, diversified RRSP portfolio. I’m not necessarily looking to add further healthcare exposure, but am very interested in the long term prospects for MRK +/- ISRG and would appreciate your opinion on them. And compared to my existing companies, would there be a suggested ranking of these six in terms of potential for long term compounding growth?

Q: I own Abbvie already and would like to add another company from the health care sector. What would be your next choice for a long term hold in a dividend focused portfolio? Considering maybe JNJ, PFE, BMY, AMGN, ABT, MRK.

Q: I am planning to reduce my health care listings and sell one of these. Was thinking about letting BMY go. What is your opinion about BMY? In order, which ones have the best prospects for the future in terms of dividends and growth?

Q: i have held this for about 5 years and it has basically done nothing despite all the promises from management for change/consolidation etc. Would you support continuing to hold or am i better switching to a better growth name. i am retired so i like a bit of income in addition to share price appreciation. i already own ABBV and MDT and do not want to add to these positions. i am better off in Merck or PFE?

Q: Hello, I am thinking about swapping BMY for Nucor. Any red flags or reasons not to do so?

Q: I am looking to add 1 or 2 U. S. Healthcare companies to my U. S. cash account. Of the 4 above could you list them in order from best to worst with a comment on thier financial and growth situation. Please include any other choices that you might add to my list.
Much appreciated.
John

Q: Hi 5i,
Current shareholder of BMY for last 4 years and it simply has not done very much however pays small dividend of 3.2 %
I'm looking to sell and replace with something in same sector/space with better share price growth potential. Medium risk with 2- 3 year horizon. Dividend would be nice but not absolutely necessary.
Thx
Jim

Q: In the healthcare sector I hold ABBV, BMY, MDT, AZN and CVS. Am looking to swap one out for a growth/value holding, perhaps in Industrials (maybe LMT?). Was thinking AZN would be my odd one out. Would appreciate your thoughts on best approach for long term buy and hold portfolio given the 5 holdings noted here. Thanks.

Q: Your thoughts please about putting new money into JNJ. Also, a couple of preferred alternative suggestions if it isn’t your first choice.

Q: I would like your opinion on purchasing either Walgreens or Bristol Myers. I'm mainly interested in the dividend. Which one would you choose for long term dividend growth and safety. Thanks.

Q: Can I get your thoughts on the valuation of the healthcare industry? Could you provide a few picks on dividend paying healthcare stocks?

Thanks,

Joe

Q: I hold a 1.5% position in both. Would like to increase one or possibly both to 2-2.5%. Which do you think has best long term prospects? (Both have a nice dividend)
Neither seem to be significantly risky to me. Thank you for the great service.

Q: Hi there. I hold positions in ABBV, PFE, MRNA, and AMGEN. I am looking for some supplemental help in the healthcare space and considering MDT, WBA, JNJ(on pull back and aware of legal risks).

What would your opinion and/or recommendations be on these companies JNJ/WBA/MDT Do you have one or two alternatives for a dividend conscious investor?

Thank you so much.
Peter

Q: I currently have PFE, GILD, MDT and ABBV in my Healthcare sector. I am looking to add a couple of names - I have been looking at MRK and BMY - your opinion please on these AND can you provide some other US healthcare companies that might be of interest to you at this time. Greatly appreciate your comments.
Thanks

Q: Hello 5i,

Of ABBV, SGEN, AMGN, BMY which are considered under-valued?
Please rank the above for a 5+ year investment?
Thank you

Cheers,
Debbie and Jerry

Q: Hi Guys,
I would like your expert opinion on the following stocks, VOYA, BMY, GM and EQH. My portfolio contains a combination of growth and income stocks. Would you consider the aforementioned to be buys, holds or sells?

Q: Dear Sirs,
What do you think of BMY at this time? Do you think it's too early to be buying these guys? I don't see anything they're doing regarding coronavirus treatment, so they may keep falling for awhile. They've done some good stuff recently: acquired Celgene (cancer) and Medarex (cancer) and have a leading drug partnered with Pfizer (prevention of blood clots caused by atrial fibrillation). They're down to about $49 from about $65 a month ago (like everyone). Thank you.

Q: Good morning team, with my celg shares gone, replaced with bmy and bmy.rt , my question is what to do with the bmy rights. Sell , hold or what will they may be worth in the future? Any thoughts?

Thanks, Michael

Q: With the world feeling a little uneasy about a pending recession, I want to keep only holdings that will weather a downturn. I'm not trying to time the market, and want to hold stocks, that while they may dip, have good balance sheets, good management, and will likely see a recovery. Others I will sell and hold the cash. Above are my current holdings. Do you see any that may be susceptible to excessive weakness in a recession and would therefore meet my sell criterion? Thanks,
Kim

Q: What do you think about BMY at this time? Debt going to be a problem? Recent actions re Celgene positive in your opinion? Thanks